Diagnostics News and Research

RSS

QIAGEN receives CE conformity marking for careHPV Test

QIAGEN has completed European certification of its careHPV™ Test to bring human papillomavirus (HPV) testing to public-health programs in low-resource, developing countries, the company announced today at the International Papillomavirus Conference in Montreal, Canada. The CE conformity marking ("Conformite Europeenne") certifies that the careHPV Test has met European Union consumer safety and health requirements, allowing the test to be distributed in developing countries that recognize the CE mark.

From QIAGEN Manchester Limited 7 Jul 2010

Hologic enters definitive agreement to acquire Sentinelle Medical

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today that it has entered into a definitive agreement to acquire Sentinelle Medical Inc., a leading provider of Magnetic Resonance Imaging (MRI) breast coils, tables and visualization software.

From Hologic, Inc. 7 Jul 2010

Biomagnetics Diagnostics signs new CRADA with Los Alamos National Security

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced the signing of a new Cooperative Research and Development Agreement with Los Alamos National Security, LLC for the development of a waveguide-based integrated optical biosensor platform for the detection of disease causing pathogens.

7 Jul 2010

IRIS wins Premier healthcare alliance's fifth annual Pinnacle Award

IRIS International, Inc., a leading manufacturer of urinalysis systems and consumables for use in hospitals and commercial laboratories worldwide, announced today that it is the winner of the fifth annual Pinnacle Award presented by the Premier healthcare alliance.

6 Jul 2010

Protagen, Mikrogen collaborate to identify typical autoantibody signatures in infectious diseases

Protagen AG, Dortmund, and the Neuried, Germany, based diagnostics company Mikrogen GmbH, announced today the closing of a collaboration agreement for the identification of typical autoantibody signatures in infectious diseases.

6 Jul 2010

AMPS, TC3 announce affiliate partnership to expand healthcare cost containment offerings

Advanced Medical Pricing Solutions and TC3 Health, Inc. recently announced an affiliate partnership to expand the healthcare cost containment offerings of both companies. TC3 is the premier provider of fraud, waste and abuse detection services for healthcare payers throughout the United States. Since 2000, TC3 has provided integrated loss control solutions to health care payers on a pre-payment and post-payment basis through its TruClaim Payment Integrity Platform.

5 Jul 2010

Recent releases in global health

Looking ahead to AIDS 2010 which will be held in Vienna, Austria, July 18-23, a Lancet editorial writes that 2010 marks "the deadline set by global leaders to achieve universal access to HIV prevention, treatment, and care. Sadly, the world will not meet these ambitious goals." However, the latest issue of the Lancet "offers some new insights to progress," the editorial notes.

3 Jul 2010

Neogenix Oncology files patent application with USPTO for 16C3 antigen

Neogenix Oncology announced today that the company has filed a patent application with the U.S. Patent and Trade Office (USPTO) for the 16C3 antigen. The Company believes that this antigen is tumor specific for pancreatic and colorectal tumors; and, based on preliminary clinical data, may also have diagnostic utility as a biomarker for these cancers.

3 Jul 2010

BIDMC calls for new training program for personalized healthcare

The Department of Pathology at Beth Israel Deaconess Medical Center (BIDMC) have issued "A Call to Action" for the medical profession to catch up with the technology and business communities in the application of genomics to personalized health care.

2 Jul 2010

FIOCRUZ receives Brazil's Anvisa regulatory approval to market Chembio's Dual Path Platform HIV 1/2 rapid test

Chembio Diagnostics, Inc., which develops, manufactures, markets and licenses point-of-care diagnostic tests, has been notified that Bio-Manguinhos, a division of the Oswaldo Cruz Foundation of Brazil ("FIOCRUZ"), has received regulatory approval from Brazil's National Health Surveillance Agency (Anvisa) to market Chembio's Dual Path Platform (DPP®) HIV 1/2 rapid test for use with oral fluid, blood, serum or plasma samples. The approval triggers $400,000 in license revenues payable to Chembio within 120 days of the date of approval.

1 Jul 2010

IRIS submits 510(k) application for clearance of iChemVELOCITY and iRICELL Urinalysis Workstation

IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, announced today that its IRIS Diagnostics Division submitted on June 30, 2010, a 510(k) pre-market notification application to the U.S. Food and Drug Administration (FDA) requesting regulatory clearance for its iChem®Velocity™ Automated Urine Chemistry Analyzer and iRICELL® Urinalysis Workstation.

1 Jul 2010

BioImagene, KUMC partner to develop Companion Algorithms for digital pathology

BioImagene, Inc., the leading provider of innovative digital pathology solutions, announced a collaboration with the University of Kansas Medical Center (KUMC) Department of Pathology & Laboratory Medicine to develop Companion Algorithms™ for next generation companion diagnostics for digital pathology.

1 Jul 2010

Roche, IBM announce agreement to develop nanopore-based sequencer for decoding human DNA

Roche and IBM announced today an agreement to develop a nanopore-based sequencer that will directly read and decode human DNA quickly and efficiently. Focused on advancing IBM's recently published "DNA Transistor" technology, the collaboration will take advantage of IBM's leadership in microelectronics, information technology and computational biology and Roche's expertise in medical diagnostics and genome sequencing.

1 Jul 2010

GSD signs agreement with Axis-Shield to distribute its proprietary assays in the U.S. Market

Gold Standard Diagnostics, Inc. a leading supplier of products and services to the medical diagnostic industry today announced the execution of an agreement with Axis-Shield to distribute their proprietary assays in the U.S. Market. Axis-Shield owns a number of patents in the areas of cardiovascular and neurodegenerative diseases, rheumatoid arthritis, diabetes and more recently, sepsis. GSD will initially focus on distribution of Homocysteine, but also gains access to distribute Axis-Shield's other key products such as Anti-CCP.

1 Jul 2010

Khon Kaen University deploys Aruba's adaptive Wi-Fi networks and AirWave Wireless Management System

Aruba Networks, Inc., a global leader in distributed enterprise network solutions, today announced that Thailand's Khon Kaen University Faculty of Medicine has deployed its adaptive Wi-Fi networks and AirWave Wireless Management System to support X-Ray image archiving, healthcare and drug dosage record access, and Internet access to 2,000 staff members and 1,200 students. The new system replaces legacy Cisco and 3COM autonomous FAT access points, and was deployed by Aruba authorized partner World Information Technology Company.

30 Jun 2010

USPTO grants Vermillion Alzheimer's disease biomarker patent

Vermillion, Inc., a molecular diagnostics company, today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance of a patent entitled "Biomarkers for Alzheimer's disease" to the Company.

29 Jun 2010

Claros point-of-care system for PSA receives European CE Mark approval

Claros Diagnostics, a developer of novel point-of-care in vitro diagnostic systems, today announced the CE Mark approval for its rapid quantitative point-of-care diagnostic platform, which can now be used for prostate specific antigen (PSA) testing throughout the European Union. The approved system consists of a small portable analyzer and credit card-sized disposable.

29 Jun 2010

Signature Dx obtains worldwide license to Affymetrix microarray technology for development of CRC tests

Affymetrix, Inc. and Signature Diagnostics AG today announced that they have signed a Powered by Affymetrix™ (PbA) agreement. Under the agreement, Signature Dx obtains a worldwide license to use Affymetrix® microarray technology to develop and commercialize diagnostic and prognostic colorectal cancer (CRC) tests.

29 Jun 2010

Response Biomedical signs subscription agreement for C$8 million private placement

Response Biomedical Corporation announced today the signing of a subscription agreement providing for the sale of C$8 million of its common shares to funds affiliated with OrbiMed Advisors, LLC. The closing of the private placement is subject to receipt of all necessary regulatory approvals, including the approval of the Toronto Stock Exchange and the shareholders of the Company.

29 Jun 2010

Shrink Nanotechnologies, Lydall enter technology integration and development agreement

Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that it has entered into a technology integration and development agreement with Lydall, Inc..

29 Jun 2010

Diagnostics News and Research

QIAGEN receives CE conformity marking for careHPV Test

Hologic enters definitive agreement to acquire Sentinelle Medical

Biomagnetics Diagnostics signs new CRADA with Los Alamos National Security

IRIS wins Premier healthcare alliance's fifth annual Pinnacle Award

Protagen, Mikrogen collaborate to identify typical autoantibody signatures in infectious diseases

AMPS, TC3 announce affiliate partnership to expand healthcare cost containment offerings

Recent releases in global health

Neogenix Oncology files patent application with USPTO for 16C3 antigen

BIDMC calls for new training program for personalized healthcare

FIOCRUZ receives Brazil's Anvisa regulatory approval to market Chembio's Dual Path Platform HIV 1/2 rapid test

IRIS submits 510(k) application for clearance of iChemVELOCITY and iRICELL Urinalysis Workstation

BioImagene, KUMC partner to develop Companion Algorithms for digital pathology

Roche, IBM announce agreement to develop nanopore-based sequencer for decoding human DNA

GSD signs agreement with Axis-Shield to distribute its proprietary assays in the U.S. Market

Khon Kaen University deploys Aruba's adaptive Wi-Fi networks and AirWave Wireless Management System

USPTO grants Vermillion Alzheimer's disease biomarker patent

Claros point-of-care system for PSA receives European CE Mark approval

Signature Dx obtains worldwide license to Affymetrix microarray technology for development of CRC tests

Response Biomedical signs subscription agreement for C$8 million private placement

Shrink Nanotechnologies, Lydall enter technology integration and development agreement

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News